Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction
Sponsor: Muhammad Aamir Latif
Summary
The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.
Official title: Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction With Oligohydramnios.
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2026-04-01
Completion Date
2026-09-30
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
Enoxaparin
Patients will receive standard management plus enoxaparin 40 mg subcutaneously once daily until delivery
Standard Management
Patients will continue with standard management alone.
Locations (1)
Combined Military Hospital
Quetta, Balochistan, Pakistan